Albion Financial Group UT Acquires 166 Shares of The Procter & Gamble Company (NYSE:PG)

Albion Financial Group UT boosted its holdings in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 0.5% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 32,738 shares of the company’s stock after acquiring an additional 166 shares during the quarter. Albion Financial Group UT’s holdings in Procter & Gamble were worth $5,670,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in PG. HighPoint Advisor Group LLC bought a new position in shares of Procter & Gamble in the fourth quarter valued at approximately $17,696,000. Bayesian Capital Management LP raised its position in shares of Procter & Gamble by 43.0% in the fourth quarter. Bayesian Capital Management LP now owns 52,840 shares of the company’s stock valued at $7,743,000 after purchasing an additional 15,900 shares during the period. Steele Capital Management Inc. bought a new position in shares of Procter & Gamble in the first quarter valued at approximately $204,000. United Advisor Group LLC bought a new position in shares of Procter & Gamble in the fourth quarter valued at approximately $3,463,000. Finally, GAMMA Investing LLC raised its position in shares of Procter & Gamble by 67.2% in the second quarter. GAMMA Investing LLC now owns 26,803 shares of the company’s stock valued at $4,420,000 after purchasing an additional 10,777 shares during the period. Institutional investors own 65.77% of the company’s stock.

Procter & Gamble Stock Down 0.2 %

Shares of NYSE:PG opened at $168.95 on Friday. The Procter & Gamble Company has a 52 week low of $141.66 and a 52 week high of $177.94. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.53 and a current ratio of 0.73. The company’s fifty day moving average is $171.45 and its 200-day moving average is $166.66. The company has a market capitalization of $398.75 billion, a PE ratio of 28.06, a P/E/G ratio of 3.67 and a beta of 0.41.

Procter & Gamble (NYSE:PGGet Free Report) last issued its earnings results on Tuesday, July 30th. The company reported $1.40 EPS for the quarter, beating the consensus estimate of $1.37 by $0.03. Procter & Gamble had a net margin of 17.71% and a return on equity of 33.46%. The company had revenue of $20.53 billion for the quarter, compared to the consensus estimate of $20.69 billion. During the same quarter in the previous year, the company earned $1.37 EPS. The firm’s revenue for the quarter was down .1% compared to the same quarter last year. Equities research analysts predict that The Procter & Gamble Company will post 6.97 earnings per share for the current fiscal year.

Procter & Gamble Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be paid a $1.0065 dividend. The ex-dividend date of this dividend is Friday, October 18th. This represents a $4.03 annualized dividend and a dividend yield of 2.38%. Procter & Gamble’s dividend payout ratio is presently 66.94%.

Insider Activity

In related news, insider Balaji Purushothaman sold 8,842 shares of Procter & Gamble stock in a transaction dated Thursday, August 1st. The stock was sold at an average price of $164.90, for a total value of $1,458,045.80. Following the completion of the transaction, the insider now directly owns 11,537 shares of the company’s stock, valued at $1,902,451.30. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. In related news, CEO R. Alexandra Keith sold 3,373 shares of Procter & Gamble stock in a transaction dated Monday, August 5th. The stock was sold at an average price of $170.00, for a total value of $573,410.00. Following the completion of the transaction, the chief executive officer now directly owns 21,513 shares of the company’s stock, valued at $3,657,210. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Balaji Purushothaman sold 8,842 shares of Procter & Gamble stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $164.90, for a total value of $1,458,045.80. Following the completion of the transaction, the insider now directly owns 11,537 shares of the company’s stock, valued at $1,902,451.30. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 383,194 shares of company stock worth $65,140,718. Corporate insiders own 0.18% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on PG shares. Barclays lowered shares of Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price target on the stock. in a research report on Monday, September 30th. Wolfe Research upgraded shares of Procter & Gamble to a “strong-buy” rating in a research note on Friday, August 23rd. DZ Bank upgraded shares of Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 price objective on the stock in a research note on Thursday, August 29th. Deutsche Bank Aktiengesellschaft raised their price objective on shares of Procter & Gamble from $171.00 to $176.00 and gave the stock a “buy” rating in a research note on Wednesday, July 17th. Finally, Citigroup raised their price objective on shares of Procter & Gamble from $177.00 to $190.00 and gave the stock a “buy” rating in a research note on Wednesday, July 10th. Ten research analysts have rated the stock with a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $175.05.

View Our Latest Report on PG

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Further Reading

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.